Affiliation:
1. Elazığ Ruh Sağlığı ve Hastalıkları Hastanesi, Elazığ, Türkiye
2. elazığ fethi sekin şehir hastanesi
Abstract
The combination of sodium valproate-valproic acid, commonly used to treat epilepsy and bipolar disor-der, may result in cutaneous reactions. In this case report, we presented a bilateral postauricular sebor-rheic dermatitis associated with sodium valproate-valproic acid use. A sodium valproate-valproic acid combination was introduced to the therapy of a 68-year-old male patient who had been diagnosed with schizophrenia and was on clozapine in order to potentially avoid seizures associated to the medication. On the fifteenth day of drug addition, crusting appeared on the back skin of both ears of the patient. While the patient had a history of clozapine use, there was no history of sodium valproate use or similar cutaneous symptoms. The current condition was associated with the sodium valproate-valproic acid combination and the drug was discontinued. Following discontinuation of the medication, the crusting decreased and disappeared completely after two weeks. The patient's schizophrenia-related treatment was completed and he was discharged. No cutaneous reaction was observed again during follow-up. It should be noted that cutaneous reactions may be associated with the use of sodium valproate-valproic acid combination.
Publisher
Canakkale Onsekiz Mart University
Reference24 articles.
1. 1. Williams AM, Park SH. Seizure associated with clozapine: incidence, etiology, and management. CNS Drugs 2015;29(2):101–11.
2. 2. Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. The pharmacogenomics of valproic acid. J Hum Genet 2017;62(12):1009–14.
3. 3. Swaiman KF, Ashwal S. Pediatric Neurolo-gy Principles and Practice. St. Louis, Mis-souri: Mosby, 3th Edition, 1999; 629–718.
4. 4. https://titck.gov.tr/storage/Archive/2020/kubKtAttachments/UYGUNKT_a3ee1b7b-cfc3-41af-b96c-4494a0928734.pdf. Date of Access: 14/10/2023.
5. 5. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA.